DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS

Nov 14, 2022, 12:00 AM

Episode image
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how exposure to high-efficacy DMTs is linked to an increased risk of cervical abnormalities in women with MS.

He also reads another news article on Tecfidera reducing the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/